{"id":"https://openalex.org/W2803928489","doi":"https://doi.org/10.2147/ott.s165840","title":"Bacillus Calmette\u2013Gu\u00e9rin and anti-PD-L1 combination therapy boosts immune response against bladder cancer","display_name":"Bacillus Calmette\u2013Gu\u00e9rin and anti-PD-L1 combination therapy boosts immune response against bladder cancer","publication_year":2018,"publication_date":"2018-05-01","ids":{"openalex":"https://openalex.org/W2803928489","doi":"https://doi.org/10.2147/ott.s165840","mag":"2803928489","pmid":"https://pubmed.ncbi.nlm.nih.gov/29844686","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/5962256"},"language":"en","primary_location":{"id":"doi:10.2147/ott.s165840","doi":"https://doi.org/10.2147/ott.s165840","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s165840","pdf_url":"https://www.dovepress.com/getfile.php?fileID=42115","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.dovepress.com/getfile.php?fileID=42115","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5101416993","display_name":"Yonghua Wang","orcid":"https://orcid.org/0000-0002-8861-1003","observed_orcids":["https://orcid.org/0000-0002-8861-1003"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yonghua Wang","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jing Liu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210116869","display_name":"Affiliated Hospital of Qingdao University","ror":"https://ror.org/026e9yy16","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210116869"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jing Liu","raw_affiliation_strings":["Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pediatrics, The Affiliated Hospital of Qingdao University, Qingdao 266000, People's Republic of China","institution_ids":["https://openalex.org/I4210116869"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071612651","display_name":"Xuecheng Yang","orcid":"https://orcid.org/0000-0002-5269-2876","observed_orcids":["https://orcid.org/0000-0002-5269-2876"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xuecheng Yang","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100387399","display_name":"Yanan Liu","orcid":"https://orcid.org/0000-0002-0091-7068","observed_orcids":["https://orcid.org/0000-0002-0091-7068"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanan Liu","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100371088","display_name":"Yong Liu","orcid":"https://orcid.org/0000-0001-5102-0309","observed_orcids":["https://orcid.org/0000-0001-5102-0309"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yong Liu","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102786296","display_name":"Yanjiang Li","orcid":"https://orcid.org/0000-0001-6767-4171","observed_orcids":["https://orcid.org/0000-0001-6767-4171"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Yanjiang Li","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100785112","display_name":"Lijiang Sun","orcid":"https://orcid.org/0000-0001-5856-8270","observed_orcids":["https://orcid.org/0000-0001-5856-8270"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lijiang Sun","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101798591","display_name":"Xiaokun Yang","orcid":"https://orcid.org/0000-0003-0234-1143","observed_orcids":["https://orcid.org/0000-0003-0234-1143"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Xiaokun Yang","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5083702713","display_name":"Haitao Niu","orcid":"https://orcid.org/0000-0001-5140-5487","observed_orcids":["https://orcid.org/0000-0001-5140-5487"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Haitao Niu","raw_affiliation_strings":["Department of Urology"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Urology","institution_ids":[]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5083702713","https://openalex.org/A5101798591"],"corresponding_institution_ids":[],"apc_list":{"value":2836,"currency":"USD","value_usd":2836},"apc_paid":{"value":2836,"currency":"USD","value_usd":2836},"fwci":3.34,"has_fulltext":true,"cited_by_count":69,"citation_normalized_percentile":{"value":0.94973605,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":96,"max":99},"biblio":{"volume":"Volume 11","issue":null,"first_page":"2891","last_page":"2899"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.5609999895095825,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10458","display_name":"Bladder and Urothelial Cancer Treatments","score":0.4302000105381012,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/bcg-vaccine","display_name":"BCG vaccine","score":0.9480000138282776},{"id":"https://openalex.org/keywords/pd-l1-blockade","display_name":"PD-L1 blockade","score":0.8510000109672546},{"id":"https://openalex.org/keywords/bladder-cancer","display_name":"bladder cancer","score":0.7879999876022339},{"id":"https://openalex.org/keywords/pd-l1-expression","display_name":"PD-L1 expression","score":0.9139999747276306},{"id":"https://openalex.org/keywords/immune-checkpoint-blockade","display_name":"immune checkpoint blockade","score":0.8050000071525574},{"id":"https://openalex.org/keywords/combination-immunotherapy","display_name":"combination immunotherapy","score":0.8209999799728394},{"id":"https://openalex.org/keywords/tlr4","display_name":"TLR4","score":0.847000002861023},{"id":"https://openalex.org/keywords/mapk-signaling","display_name":"MAPK signaling","score":0.8140000104904175},{"id":"https://openalex.org/keywords/cd8-tumor-infiltrating-lymphocytes","display_name":"tumor-infiltrating CD8+ T cells","score":0.8999999761581421},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":1.0},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.8529999852180481}],"concepts":[{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6976402997970581},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.6405699849128723},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.6077961325645447},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5886861681938171},{"id":"https://openalex.org/C154317977","wikidata":"https://www.wikidata.org/wiki/Q376266","display_name":"Cytotoxic T cell","level":3,"score":0.5752469301223755},{"id":"https://openalex.org/C2781053074","wikidata":"https://www.wikidata.org/wiki/Q21100639","display_name":"PD-L1","level":4,"score":0.5462299585342407},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5340826511383057},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4658321738243103},{"id":"https://openalex.org/C2780851360","wikidata":"https://www.wikidata.org/wiki/Q21686041","display_name":"Immune checkpoint","level":4,"score":0.4540579319000244},{"id":"https://openalex.org/C167672396","wikidata":"https://www.wikidata.org/wiki/Q417800","display_name":"CD8","level":3,"score":0.42981404066085815},{"id":"https://openalex.org/C147969180","wikidata":"https://www.wikidata.org/wiki/Q5014579","display_name":"CTL*","level":4,"score":0.42677342891693115},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2245820164680481},{"id":"https://openalex.org/C202751555","wikidata":"https://www.wikidata.org/wiki/Q221681","display_name":"In vitro","level":2,"score":0.18685877323150635},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0}],"mesh":[],"locations_count":6,"locations":[{"id":"doi:10.2147/ott.s165840","doi":"https://doi.org/10.2147/ott.s165840","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s165840","pdf_url":"https://www.dovepress.com/getfile.php?fileID=42115","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},{"id":"pmh:oai:europepmc.org:4922775","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5962256","pdf_url":null,"source":{"id":"https://openalex.org/S4306400806","display_name":"Europe PMC (PubMed Central)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1303153112","host_organization_name":"European Bioinformatics Institute","host_organization_lineage":["https://openalex.org/I1303153112"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":null,"raw_type":"Text"},{"id":"pmh:oai:pubmedcentral.nih.gov:5962256","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/5962256","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Onco Targets Ther","raw_type":"Text"},{"id":"pmid:29844686","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/29844686","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and therapy","raw_type":"Journal Article"},{"id":"pmh:oai:doaj.org/article:69b0a9fe664740dbb042330f325d9d60","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/69b0a9fe664740dbb042330f325d9d60","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"OncoTargets and Therapy, Vol Volume 11, Pp 2891-2899 (2018)","raw_type":"article"},{"id":"pmh:oai:dovepress.com/38338","doi":null,"is_oa":true,"landing_page_url":"https://www.dovepress.com/bacillus-calmette-guerin-and-anti-pd-l1-combination-therapy-boosts-imm-peer-reviewed-article-OTT","pdf_url":null,"source":{"id":"https://openalex.org/S4306401012","display_name":"Dove Medical Press (Taylor and Francis Group)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.2147/ott.s165840","doi":"https://doi.org/10.2147/ott.s165840","is_oa":true,"landing_page_url":"https://doi.org/10.2147/ott.s165840","pdf_url":"https://www.dovepress.com/getfile.php?fileID=42115","source":{"id":"https://openalex.org/S120324992","display_name":"OncoTargets and Therapy","issn_l":"1178-6930","issn":["1178-6930"],"is_oa":true,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","poland-70","russia-white-list-2"],"host_organization":"https://openalex.org/P4310320348","host_organization_name":"Dove Medical Press","host_organization_lineage":["https://openalex.org/P4310320348","https://openalex.org/P4310320547"],"host_organization_lineage_names":["Dove Medical Press","Taylor & Francis"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"OncoTargets and Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G5251714531","display_name":null,"funder_award_id":"81101932","funder_id":"https://openalex.org/F4320321001","funder_display_name":"National Natural Science Foundation of China"}],"funders":[{"id":"https://openalex.org/F4320321001","display_name":"National Natural Science Foundation of China","ror":"https://ror.org/01h0zpd94"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2803928489.pdf","grobid_xml":"https://content.openalex.org/works/W2803928489.grobid-xml"},"referenced_works_count":29,"referenced_works":["https://openalex.org/W1966900148","https://openalex.org/W2035660473","https://openalex.org/W2039123767","https://openalex.org/W2052727153","https://openalex.org/W2064352891","https://openalex.org/W2079018735","https://openalex.org/W2099786413","https://openalex.org/W2112601576","https://openalex.org/W2113140685","https://openalex.org/W2137114442","https://openalex.org/W2156383220","https://openalex.org/W2160834915","https://openalex.org/W2168020987","https://openalex.org/W2211471240","https://openalex.org/W2398385357","https://openalex.org/W2509486054","https://openalex.org/W2560367415","https://openalex.org/W2570618306","https://openalex.org/W2588146309","https://openalex.org/W2618557910","https://openalex.org/W2647469809","https://openalex.org/W2649542682","https://openalex.org/W2709087835","https://openalex.org/W2755671606","https://openalex.org/W2771183993","https://openalex.org/W2795095935","https://openalex.org/W2916183155","https://openalex.org/W4238423864","https://openalex.org/W4256360038"],"related_works":["https://openalex.org/W2892779818","https://openalex.org/W4306884778","https://openalex.org/W2532217238","https://openalex.org/W2344459451","https://openalex.org/W3159254532","https://openalex.org/W2181394591","https://openalex.org/W6995927584","https://openalex.org/W2918536559","https://openalex.org/W7162668300","https://openalex.org/W3042600977"],"abstract_inverted_index":{"Background:":[0],"Programmed":[1],"death-ligand":[2],"1":[3],"(PD-L1)":[4],"is":[5],"a":[6,161],"critical":[7],"immune":[8,45,164],"checkpoint":[9],"molecule":[10],"which":[11,35],"promotes":[12],"immunosuppression":[13],"by":[14],"binding":[15],"to":[16,83,145,202,223],"PD-1":[17],"on":[18,108],"T-cells":[19],"in":[20,40,56,111,125,140,143,149,152,169,184,221],"tumor":[21,193],"immunity.":[22],"We":[23,132],"have":[24],"previously":[25],"identified":[26],"that":[27,134,228],"activation":[28],"of":[29,43,74,105,119,174,219,230,246],"toll":[30],"like":[31],"receptor":[32],"4":[33],"(TLR-4),":[34],"serves":[36],"an":[37,238],"important":[38],"role":[39],"the":[41,62,72,85,103,117,167,170,182,215],"induction":[42],"antitumor":[44,163,240],"response":[46,144,165,222],"during":[47],"Bacillus":[48],"Calmette\u2013Gu\u00e9rin":[49],"(BCG)":[50],"immunotherapy,":[51,253],"could":[52],"upregulate":[53],"PD-L1":[54,90,109,135,220,234],"expression":[55,91,110,136],"bladder":[57,251],"cancer":[58],"(BCa)":[59],"cells":[60,113,142,187],"through":[61],"classical":[63],"mitogen-activated":[64],"protein":[65],"kinase":[66],"(MAPK)":[67],"pathway":[68],"and":[69,92,96,114,121,151,156,172,189,196,199,226],"subsequently":[70],"weaken":[71],"cytotoxicity":[73],"cytotoxic":[75],"T":[76,177],"lymphocyte":[77],"(CTL).":[78],"It":[79],"is,":[80],"therefore,":[81],"necessary":[82],"investigate":[84],"possible":[86],"potential":[87],"relationship":[88],"between":[89],"BCG":[93,106,120,146,155,224,231],"immunotherapy.":[94],"Materials":[95],"methods:":[97],"In":[98],"this":[99],"study":[100],"we":[101],"investigated":[102],"effects":[104],"treatment":[107,147,159,244],"BCa":[112,129,141],"also":[115],"evaluated":[116],"efficacy":[118],"anti-PD-L1":[122,157],"combination":[123,158,229,254],"therapy":[124,255],"immunocompetent":[126],"orthotopic":[127],"rat":[128],"models.":[130],"Results:":[131],"found":[133,201],"was":[137,200],"obviously":[138],"upregulated":[139],"both":[148],"vitro":[150],"vivo.":[153],"Moreover,":[154],"activated":[160],"potent":[162],"with":[166,233],"increase":[168],"number":[171],"activity":[173],"tumor-infiltrating":[175],"CD8+":[176],"cells,":[178],"as":[179,181],"well":[180],"reduction":[183],"myeloid-derived":[185],"suppressor":[186],"(MDSCs),":[188],"eventually":[190],"elicits":[191],"prominent":[192],"growth":[194],"inhibition":[195],"prolonged":[197],"survival,":[198],"be":[203,237],"much":[204],"more":[205],"effective":[206,239],"than":[207],"either":[208],"agent":[209],"alone.":[210],"Conclusion:":[211],"These":[212],"findings":[213],"highlight":[214],"adaptive":[216],"dynamic":[217],"regulation":[218],"immunotherapy":[225,232],"suggest":[227],"blockade":[235],"may":[236],"strategy":[241],"for":[242],"improving":[243],"outcomes":[245],"BCa.":[247],"Keywords:":[248],"BCG,":[249],"PD-L1,":[250],"cancer,":[252]},"counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":9},{"year":2023,"cited_by_count":8},{"year":2022,"cited_by_count":4},{"year":2021,"cited_by_count":9},{"year":2020,"cited_by_count":10},{"year":2019,"cited_by_count":10},{"year":2018,"cited_by_count":3}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2018-06-01T00:00:00"}